Company dossier
BIOMET INC
Exchange
—
Entity type
operating
Fiscal year end
May 31
Headquarters
IN
Company overview
BIOMET INC stands as a veteran player in Orthopedic, Prosthetic & Surgical Appliances & Supplies, a sector historically tracked under SIC 3841, offering joint-replacement components, spinal devices, surgical instruments, and related prosthetic technologies to hospitals, orthopedic surgeons, and specialty clinics worldwide. Its engineering-focused portfolio serves populations with degenerative joint disease, trauma repair needs, and complex spinal disorders, bundling implants with implantable systems and service support that healthcare providers count on for reliability and surgical precision. The firm navigates material regulatory oversight from the FDA, Health Canada, and European notified bodies—where device approvals, quality-system compliance, and post-market surveillance hinge on rigorous clinical data—while supply-chain disruptions or recalls could pose earnings risks, as could shifts in reimbursement policies that squeeze hospital capital budgets. CIK 351346 files late-1990s-era disclosures, most recently a December 1999 Form 8-K, reflecting both a long reporting history and the need for current insight; view live SEC filings on Earnings Feed.
Source: Earnings Feed research · last updated 11/24/2025
Recent filings
- BIOMET INC7.0 KB
BIOMET INC 8-K
- BIOMET INC38.8 KB
BIOMET INC 10-Q
- BIOMET INC222.4 KB
BIOMET INC 10-K
- BIOMET INC45.2 KB
BIOMET INC 10-Q
- BIOMET INC44.5 KB
BIOMET INC 10-Q
- BIOMET INC43.9 KB
BIOMET INC 10-Q
- BIOMET INC271.6 KB
BIOMET INC 10-K